High Throughput Screening: An Insider's Guide to Outsourcing, New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - May 25, 2016) - In this webinar, industry expert David Cronk, Director of Hit Discovery at Charles River Laboratories, will provide an overview of high throughput screening process from assay development through to the final data package by exploring examples of successful screening programs conducted at Charles River Laboratories.
High throughput screening (HTS) is an established means to identify starting points in the drug discovery process. As a significant investment is necessary to undertake high throughput screening efficiently, screening is increasingly being outsourced by researchers in the not-for-profit, biotechnology and pharmaceutical sectors. Access to high throughput screening expertise and technology without the need to implement in-house compound libraries and the required screening and data handling platforms has proven effective at reducing operational and infrastructure costs.
During the course of the discussion, Cronk will describe various assay options in common use and whether highly miniaturized and/or automated platforms are applicable in all situations. Drilling into the details common to these successful programs will reveal insights on points to consider and questions to ask when considering different labs to work with on projects.
Webinar Objectives:
- Explain the screening process from assay development to final data package
- Describe assay options and which platforms are applicable for different types of projects
- Provide insight on key points to consider when outsourcing
Join the live broadcast on Tuesday, June 14, 2016 at 11am EDT (4pm BST/UK). For more information or to register for this complimentary event, visit: High Throughput Screening: An Insider's Guide to Outsourcing
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2016/5/24/11G099883/Images/discovery_brand_mark_x500-a5d2241a4675bb6ab665a84cbaebac77.jpg
Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com
As your scientific partner and preclinical CRO provider, Charles River provides innovation, flexibility, and efficiency in IND-enabling studies from early discovery research and in vivo pharmacology models through safety assessment.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
